Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03484299 · ClinicalTrials.gov registry record · Phase 1

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

A Phase 1 study of Pancreas Cancer, sponsored by University of Louisville.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT03484299 is a Phase 1 study of Pancreas Cancer that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 20 participants, below the 907-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03484299, a Phase 1 study of Pancreas Cancer, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Compare the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitabine in patients with locally advanced pancreatic cancer.

Conditions Studied

Pancreas Cancer

Interventions

  • DRUG Gemcitabine
  • DRUG FOLFIRINOX
  • PROCEDURE Irreversible Electroporation (IRE)

Study Locations (1)

Kentucky

  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-05-30
Est. Completion 2027-07-31
Phase Phase 1

Sponsor

University of Louisville

217 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03484299

The ClinicalTrials.gov registry entry for NCT03484299 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 907-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreas Cancer appearing as the primary indexed condition, and to 3 interventions - of which Gemcitabine is the first listed.

NCT03484299 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT03484299 about?

NCT03484299 is a clinical study titled "Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma". Compare the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitabine in patients with locally advanced pancreatic cancer.

What is the current status of trial NCT03484299?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2018-05-30. Estimated completion is 2027-07-31.

What conditions does trial NCT03484299 study?

This clinical trial studies the following conditions: Pancreas Cancer.

What interventions are being tested in trial NCT03484299?

The interventions under investigation include: Gemcitabine (DRUG), FOLFIRINOX (DRUG), Irreversible Electroporation (IRE) (PROCEDURE).

Who is sponsoring clinical trial NCT03484299?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03484299 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreas Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pancreas Cancer

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.